GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Price-to-Operating-Cash-Flow

Mydecine Innovations Group (STU:0NF0) Price-to-Operating-Cash-Flow : (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Price-to-Operating-Cash-Flow?

As of today (2024-05-16), Mydecine Innovations Group's share price is €0.009. Mydecine Innovations Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.23. Hence, Mydecine Innovations Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Mydecine Innovations Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

STU:0NF0's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.48
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Mydecine Innovations Group's Cash Flow from Operations per share for the three months ended in Sep. 2023 was €-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.23.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 33.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 56.10% per year.

During the past 10 years, Mydecine Innovations Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.90% per year. The lowest was 2.90% per year. And the median was 48.00% per year.


Mydecine Innovations Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Mydecine Innovations Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Price-to-Operating-Cash-Flow Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mydecine Innovations Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Price-to-Operating-Cash-Flow falls into.



Mydecine Innovations Group Price-to-Operating-Cash-Flow Calculation

Mydecine Innovations Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.009/-0.229
=

Mydecine Innovations Group's Share Price of today is €0.009.
Mydecine Innovations Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Mydecine Innovations Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (STU:0NF0) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines